BioCardia Inc. (BCDAW)
BioCardia Statistics
Share Statistics
BioCardia has 1.66M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 1.66M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | 0.38% |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -0.75 and the forward PE ratio is null. BioCardia's PEG ratio is 0.01.
| PE Ratio | -0.75 |
| Forward PE | n/a |
| PS Ratio | 103.13 |
| Forward PS | null |
| PB Ratio | 7.15 |
| P/FCF Ratio | -0.74 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for BioCardia.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.13, with a Debt / Equity ratio of 1.14.
| Current Ratio | 1.13 |
| Quick Ratio | 1.13 |
| Debt / Equity | 1.14 |
| Debt / EBITDA | -0.12 |
| Debt / FCF | -0.12 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $3.63K |
| Profits Per Employee | $-496.63K |
| Employee Count | 16 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 1.36, so BioCardia's price volatility has been higher than the market average.
| Beta | 1.36 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.39 |
| Relative Strength Index (RSI) | 39.09 |
| Average Volume (20 Days) | - |
Income Statement
In the last 12 months, BioCardia had revenue of 58K and earned -7.95M in profits. Earnings per share was -2.9.
| Revenue | 58K |
| Gross Profit | 58K |
| Operating Income | -8M |
| Net Income | -7.95M |
| EBITDA | -7.93M |
| EBIT | -8M |
| Earnings Per Share (EPS) | -2.9 |
Balance Sheet
The company has 2.37M in cash and 951K in debt, giving a net cash position of 1.42M.
| Cash & Cash Equivalents | 2.37M |
| Total Debt | 951K |
| Net Cash | 1.42M |
| Retained Earnings | -160.12M |
| Total Assets | 3.72M |
| Working Capital | 301K |
Cash Flow
In the last 12 months, operating cash flow was -8.03M and capital expenditures -6K, giving a free cash flow of -8.03M.
| Operating Cash Flow | -8.03M |
| Capital Expenditures | -6K |
| Free Cash Flow | -8.03M |
| FCF Per Share | -2.93 |
Margins
Gross margin is 100%, with operating and profit margins of -13794.83% and -13700%.
| Gross Margin | 100% |
| Operating Margin | -13794.83% |
| Pretax Margin | -13700% |
| Profit Margin | -13700% |
| EBITDA Margin | -13679.31% |
| EBIT Margin | -13794.83% |
| FCF Margin | -13848.28% |
Dividends & Yields
BCDAW does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for BCDAW.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -67.17 |
| Piotroski F-Score | 2 |